Importantly, we confirmed that chidamide in combination with apatinib significantly downregulated the protein levels of VEGFR, BCL2 and MCL1 in spleen and bone marrow tissues from AML PDX xenografts (Fig. 6D, E). Here, BCL2 is linked to acute myeloid leukemia.